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INTRODUCTION
e bones develop and grow by two processes, endochondral and intramembranous ossification. 
e bones of the cranial base and tibia form by endochondral ossification. During endochondral 
ossification, a cartilage template forms first. en, the cartilage template is vascularized, followed 
by recruitment of osteoclasts and osteoblasts, and then, the cartilage scaffold gradually replaced 
with bone. In the cranial base, the synchondrosis is the significant sites of growth and has a 
crucial role in determining the overall skull shape as well as relating each bone to its neighbor.[1-3] 
Furthermore, the size of the brain increased rapidly in the early age[4]. e cranial base protects 
ABSTRACT
Introduction: e synchondrosis contributes to the growth of overall skull. e growth plate of the tibia is an 
analogous structure to the synchondrosis. e fibroblast growth factor receptors (FGFRs) are known to play an 
essential role in the proliferation and differentiation of cartilaginous cells.
Methods: is study was purposed to examine the histological features of spheno-occipital synchondrosis (SOS) 
and tibial cartilage (TC) and the expression pattern of FGFR-1, -2 and proliferating cell nuclei antigen (PCNA) in 
SOS and TC of the postnatal mouse using an immunohistochemical method.
Results: e width of SOS and TC reduced with age. e width of the SOS decreased, and then maintained, 
while the width of TC decreased gradually. Expression pattern of FGFRs indicated that they were involved in 
the postnatal bone growth and development. In SOS, FGFR-1 expression increased until the 14th day, and then, 
it showed a notable decrease. Comparing the level of expression, TC showed a stronger level than SOS at most 
stages. FGFR-2 showed in the resting and proliferating zones at an earlier stage of differentiation. With age, 
FGFR-2 expression reduced in previous zone and increased in the hypertrophic zone at both tissues. In PCNA 
study, cell proliferation was active in the resting and proliferating zone at an early stage. As mouse matured, the 
PCNA-positive cells usually expressed in the newly formed endosteal bone surface.
Conclusions: is approach revealed a temporal and spatial change of FGFR-1, -2 expressions. e expression 
pattern of PCNA indicated that the chondrocytes of TC had more active metabolism than SOS at most of the 
stages. We can also speculate that FGFR-1 is a negative regulator of chondrogenesis, and FGFR-2 is a positive 
regulator of chondrogenesis.
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and supports the brain, and the synchondroses play an 
important role in integrating the bones composing cranial 
base during the growth of brain.[5] Especially, the spheno-
occipital synchondrosis (SOS) is important as it remains 
patent the longest between other synchondroses and provides 
significant growth in adolescence. In lower legs, the growth 
plate in the tibia is responsible for the longitudinal growth 
through an elaborately controlled process.[6]
Histologically, both of the synchondrosis and growth 
plate in tibia divide into three zones and, in each zone, the 
chondrocytes are at different maturation and metabolic 
stages.[7-9] At the resting zone, the cells (or chondrocytes or 
chondrogenic progenitor cells) are relatively in an inactive 
state; and then, they activate and differentiate to chondrocytes 
entering into the proliferative phase at the proliferating zone. 
en, the chondrocytes begin to increase in size, and they 
begin to synthesize collagens and form the hypertrophic 
zone, where at the lower part calcification and mineralization 
of the extracellular matrix allows.[10] At their terminal 
differentiation stage, hypertrophic chondrocytes terminate 
the life cycle by apoptosis. e calcified zone of hypertrophic 
cartilage is invaded by blood vessels, bringing in the bone-
forming cells (osteoblasts) and resorbing cells (osteoclasts), 
which will remodel and convert the mineralized cartilage 
into the trabecular bone.
Fibroblast growth factors (FGFs) consist of a family of at least 
22 heparin-binding-related proteins and are major regulators 
of embryonic bone development.[11,12] FGFs bind to a family 
of FGF receptors (FGFRs) with high affinity. Four FGFRs 
(FGFR-1,  -2,  -3, and  -4) are well known up to recently. 
e structure of the FGFRs includes (1) an extracellular 
domain, which consists of three immunoglobulins (Ig)-
like domains, (2) a transmembrane domain, and (3) an 
intracellular tyrosine kinase domain, responsible for receptor 
dimerization and cell signaling.[13] e 3rd Ig loop or the linker 
region between 2nd and 3rd Ig loop in the Ig-like domain is the 
major mutation site in FGFRs. Kinase activates when the FGF 
ligand forms a trimolecular complex with FGFR and heparan 
sulfate proteoglycans.[14-18] Mutations in FGFR-encoding 
genes have been identified to cause craniosynostoses such as 
Apert, Pfeiffer, Jackson–Weiss, and Crouzon syndromes.[19,20] 
ese FGFRs differ in their ligand specificity[21] and tissue 
distribution.[22,23] For example, in calvaria bones, FGFR-1 is 
mainly expressed in differentiated osteoblasts, while FGFR-
2 expressed in pre-osteoblasts. e principal function of 
FGFRs is in cellular behavior, such as cell proliferation and 
differentiation. e isoforms of the FGFR-1, -2, and -3 have 
been expressed at a specific area in the developing cranial 
bones, implicating its key role in the proliferation and 
differentiation for the cartilage growth.[24] Proliferating cell 
nuclear antigen (PCNA) clarifies the alternation process in 
cells and can be used as a marker for immunohistochemical 
analysis.
e purpose of this study was to investigate the postnatal 
developmental progression of the SOS and tibial cartilage 
(TC). For this purpose, the present study evaluated the 
histological changes on SOS and TC by age in postnatal 
mouse and investigated the expression of FGFR-1,  -2, and 
PCNA which are used to identify the proliferating pattern of 
chondrocytes.
MATERIALS AND METHODS
Tissue preparation
Postnatal ICR mice at 1 day, 7 days, 14 days, and 21 days of 
age were used in this study. is study was approved by the 
Animal Care and Use Committee, Yonsei Medical Center. 
e cranial bases and tibias of the mouse were dissected 
and stored in ice-cold phosphate-buffered saline (PBS). 
Following overnight fixation at 4°C in 4% paraformaldehyde 
in PBS (pH 7.4), they were decalcified with 8% formic acid 
for 1 day to 10 days, depending on their age. e decalcified 
tissues were dehydrated and embedded in paraffin. Paraffin 
sections were cut at 6 µm thickness in the mid-sagittal plane, 
in parallel to the longitudinal axis of the cranial base and 
tibia by a microtome and mounted on silane-coating slide 
glasses [Figure 1]. e slide glasses were dried overnight at 
room temperature.
Immunohistochemical staining
Immunohistochemical staining was performed on the 
dewaxed paraffin section. e midsagittal paraffin sections 
were deparaffinization and rehydration to facilitate the 
immunological reaction of antibodies with antigens in 
fixed tissue. Pretreatment was performed using a pressure 
cooker for up to 7 min in citrate buffer and then cooled in 
the room temperature for 15  min. Next, the slides were 
treated with 0.15 M ethylenediaminetetraacetic solution 
for 10  min. For enzyme digestion, the slides were placed 
in 0.2% hyaluronidase (Sigma, ST. Louis, MO, USA) 
solution at the 37°C  container for 20  min. After washing 
procedures, the slides were transferred into 10% hydrogen 
Figure  1: Mid-sagittal section of cranial base and tibia. In 
preparation for immunohistochemical stain, the skin and associated 
tissues were removed from the cranial base (a) and tibia (b). e line 
and square stand for the axis of the section. Black arrow indicates 
the spheno-occipital synchondrosis.
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peroxide/methanol for 10  min. Blocking solution (Zymed, 
San Francisco, CA, USA) was applied to the specimens for 
15 min to reduce non-specific binding. After washing several 
times, the sections were incubated with rabbit polyclonal 
primary antibodies against FGFR-1, FGFR-2, and PCNA 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted 
at 1:100, respectively, at 4°C cold room for overnight. After 
washing several times in PBS, the specimens were treated 
with a biotinylated anti-rabbit secondary antibody (Zymed, 
San Francisco, CA, USA) for 20  min at room temperature, 
and then, streptavidin HRP (Zymed, San Francisco, CA, 
USA) was conjugated on the secondary antibodies. e 
specimens were subsequently treated with diaminobenzidine 
tetrahydrochloride (Zymed, San Francisco, CA, USA) 
to visualize immunoreaction. And then, they were 
counterstained with Mayer’s Hematoxylin (Lab Vision, 
Fremont, CA, USA), dehydrated, and mounted with cover 
slide.
Histomorphometric analysis
All sections were photographed with a Leica DC 300F 
digital camera (Leica, Wetzlar, Germany). Image-Pro plus 
analyzer program (Media Cybernetics, Rockville, MD, 
USA) was used for measurement. e width of each zone 
was measured [Figure 2]. e measurement was done three 
times, and the mean values were used. e results of the 
immunohistochemical analysis were rated such as (+) weak 
intensity, (++) moderate intensity, and (+++) strong intensity.
RESULTS
The histologic morphology of SOS and TC [Figure 3]
e width of SOS and TC was reduced over time. ere 
was a reduction at all zones, resting, proliferating, and 
hypertrophic zone. e reduction of width in SOS had 
happened remarkably between 1st day and 7th day, especially 
at the hypertrophic zone and resting zone. And after 14th day, 
there was little change in the width. On the other hand, the 
width of TC was reduced gradually in every zone with age.
Expression pattern of FGFR-1 in SOS and TC [Figure 4]
FGFR-1 was expressed during development of the SOS and 
TC at all zones.
In SOS, FGFR-1 was localized mostly in the resting and 
proliferating zones at the 1st and 7th day. At 14th day, FGFR-
1 was localized broadly at all three zones with moderate-to-
strong intensity. At 21 days, the FGFR-1 was expressed weak.
In TC, FGFR-1 was strongly localized in all three zones on 
the 1st day. From the 14th day, FGFR-1 was typically expressed 
in the hypertrophic zone and newly formed endosteal bone 
surface. At the 21st day, the localization pattern was similar to 
the 14th day pattern.
Figure  3: Width changes at spheno-occipital synchondrosis and 
tibial cartilage. e width changes in spheno-occipital synchondrosis 
(SOS) and tibia cartilage (TC). ere was a reduction in all zones. 
In SOS, the width was remarkably reduced at the hypertrophic 
zone between 7th  day and 14th  day. e width of TC was reduced 
smoothly compared to SOS. RZ = Resting zone, PZ = proliferating 
zone, HZ = Hypertrophic zone (length unit is µm).
Figure 2: Distinct zones of spheno-occipital synchondrosis and tibia cartilage. Sphenooccipital synchondrosis (a) and tibia cartilage (b) can 
divide into three zones through cell shape. e cell of the resting zone is a round shape; the proliferating zone is a flattened shape; the 
hypertrophic zone is increased cell size. (photographed at ×400).
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Expression pattern of FGFR-2 in SOS and TC [Figure 5]
FGFR-2 was also presented during the development of SOS 
and TC in all zones.
In SOS, FGFR-2 was localized mostly in the resting and 
proliferating zones at the 1st  and 7th day. From the 14th day, 
the FGFR-2 expression pattern was increased at proliferating 
and hypertrophic zones. At the 21st day, the intensity was the 
strongest.
In TC, FGFR-2 was observed in all three zones at the 1st and 
7th day. From the 14th day, the expression pattern of FGFR-2 at 
resting and hypertrophic zones showed moderate-to-strong 
intensity. At the 21st day, FGFR-2 was strongly expressed in 
the proliferating zone.
Figure 5: Localization of FGFR-2 in spheno-occipital synchondrosis (SOS) and tibial cartilage (TC) at postnatal 1st day, 7th day, 14th day, and 
21st day. Two images in the center are the sagittal view of the cranial base (a) and tibia (b) stained with HE stain. e small rectangles in panel 
indicate the area enlarged SOS and TC. In SOS (left column), FGFR-2-positive cells were smoothly reduced in the proliferating zone with 
age. In TC (right column), localization of FGFR-2 was shown a similar pattern with SOS. However, the level of expression pattern in TC was 
stronger than SOS at the early stage. (SOS: ×400, TC: ×200) +++: intensity of stain is strong, ++: moderate, +: weak.
ba
Figure 4: Localization of fibroblast growth factor receptors (FGFR)-1 in spheno-occipital synchondrosis (SOS) and tibial cartilage (TC) at 
postnatal 1st day, 7th day, 14th day, and 21st day. Two images in the center are the sagittal view of cranial base (a) and tibia (b) stained with 
hematoxylin and eosin (HE) stain. e small rectangles in panel indicate the area enlarged SOS and TC. In the SOS (left column), FGFR-1 
was localized in all zones, especially in the newly formed endosteal bone surfaces. e FGFR-1-positive cells were reduced in resting and 
proliferating zones; however, they were increased in the hypertrophic zone and newly formed bone surface with age. In the tibia (right 
column), localization of FGFR-1 was shown a similar pattern with SOS. However, the level of expression pattern in the TC was stronger than 
spheno-occipital synchondrosis at an early stage. (SOS: ×400, TC: ×200) +++: intensity of stain is strong, ++: moderate, +: weak. 
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Expression patterns of PCNA in SOS and TC [Figure 6]
PCNA was presented during the development of the SOS and 
TC at all zones.
In SOS, PCNA was localized mostly in the resting and 
proliferating zones at the 1st  and 7th  day. At the 14th  day, 
PCNA was observed remarkably in all zones, especially in the 
hypertrophic zone. At the 21st day, PCNA-positive cells were 
mostly found in the hypertrophic zone and the endosteal 
bone surface.
In the TC, PCNA was observed in the resting and 
proliferation zone at the 1st  day. At the 7th  day, PCNA was 
observed in proliferating and hypertrophic zone. From 
14th  day, the level of PCNA expressed in the hypertrophic 
zone and newly formed endosteal bone surface. At 21st day, 
PCNA was rarely observed.
DISCUSSION
The importance of the cranial base and tibia in the 
development
During the fetal period, ossification centers are formed in 
the cranial base synchondrosis and TC. In the postnatal 
period, endochondral ossification of the synchondrosis and 
TC contributes to the expansion of the ossification centers 
and growth of the cranial base and tibia. By analyzing the 
time course of normal growth and development of the 
endochondral cranial base comparing with a tibia of a mouse, 
the function of the cranial base and tibia growth in terms of 
endochondral ossification during the postnatal period was 
identified. ere are few papers compared the development 
and growth of cranial base with TC during the postnatal 
period. In that respect, this experiment can be meaningful 
to identify the growth of the cranial base and TC during the 
postnatal period.
Involvement of the FGFR-1 and -2 in the endochondral 
ossification of the SOS and TC
In the endochondral bone formation, FGFR-1,  -2 isoforms 
are all present during its development. It has been known that 
there are two major splicing isoforms in the FGFRs, namely 
b-form and c-form. Previous studies showed that Fgfr2c 
transcripts were detected in the resting and proliferating zone 
of chondrocytes as well as osteoblasts in the newly formed 
endosteal bone surface of the cranial base synchondrosis.[24,25] 
Our data also show a similar pattern to previous studies 
that FGFR-1,  -2 may be involved in the growth of cranial 
base and TC growth during the postnatal period. From the 
comparison with preview studies, it can be speculated that 
the FGFRs observed in the present study are linked to being 
the c-isoform.
In immunohistochemical staining, localization of FGFR-1 
was mainly seen in the resting and proliferating zones at an 
early stage in SOS and all zones in TC. At a later stage, the 
FGFR-1 was upregulated at a hypertrophy zone.
In SOS, there seems to be a connection between the FGFR-1 
and the width of zones. After 14th day, the intensity of FGFR-
1 remarkably reduced, and the width was almost maintained. 
On the other hand, the width had decreased gradually in 
Figure  6: Localization of proliferating cell nuclei antigen (PCNA) in spheno-occipital synchondrosis (SOS) and tibial cartilage (TC) at 
postnatal 1st day, 7th day, 14th day, and 21st day. Two images in the center are the sagittal view of the cranial base (a) and tibia (b) stained with 
HE stain. e small rectangles in panel indicate the area enlarged SOS and TC. In SOS, the expression level was most active at 14 days and 
least active at 21 days. e PCNA-positive cells were increased in the bone surface with age. In TC, PCNA-positive cells were expressed at 
all three zones. e level of expression was reduced with age. As mouse matured, most of PCNA-positive cells were expressed in the bone 
surface. (SOS: ×400, TC: ×200) +++: intensity of stain is strong, ++: moderate, +: weak.
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TC, where the FGFR-1 expression had increased. It can 
be assumed that brain growth may cause this difference. 
However, further study is needed to investigate the causative 
factors.
Localization of FGFR-2 in SOS and TC was seen in the 
resting and proliferating zone at an early stage. is result 
overlaps with mRNA localization of FGFR-1 and FGFR-
2 using fetal mice and localization FGFR-1 and FGFR-2 at 
the postnatal growth plate.[26,27] ese results indicate the 
possibility that the FGFRs may be involved in the particular 
stages of chondrocyte proliferation and differentiation during 
growth. Deletion of Fgfr2c or expression of gain-of-function 
mutations in Fgfr2c in mice results in craniofacial and tibia 
abnormalities.[28,29] It was also shown that a dominant mutation 
that affects alternative splicing in FGFR-2 caused synostosis 
in mice.[30] Synchondrosis fusion and developmental 
deficiency in the basicranium of Fgfr2c null mice imply 
primary anomalies in the basicranium, simultaneously in 
the cranial vault. Loss-of-function mutations in FGFRs are 
not well known. Embryo lacking FGFR-1 or  -2 dies before 
skeletal development.[31,32] In another study, expression of 
FGFR-1 in the hypertrophic chondrocyte suggests a role in 
the survival of the hypertrophic chondrocyte, in regulating 
a feedback signal to control the rate of differentiation, 
in regulating the production of the unique extracellular 
matrix products of these cells or in signaling their eventual 
apoptotic death.[33] In our study, the FGFR-1 and FGFR-2 
were predominantly expressed both in the cartilage phase 
and in the new bone phase. ese findings imply that the 
FGFR-1 and FGFR-2 may be involved in endochondral 
ossification and osteogenesis in the chondrogenesis phase, 
especially in the hypertrophy zone by activation of cell 
proliferation and differentiation. We can suggest that FGFR-1 
expressed in the hypertrophy zone is thought to a negative 
regulator of chondrogenesis and controls the differentiation 
of the hypertrophy cells in the cartilage. Furthermore, we can 
expect that FGFR-2 expressed in the resting and proliferating 
zone is a positive regulator of chondrogenesis and control 
the proliferation and differentiation of chondrocytes in the 
process of chondrogenesis.
Localization of the PCNA in SOS and TC during the 
development
In the endochondral bone formation, PCNA is all present 
during its development. Previous studies showed that PCNA-
positive chondrocytes were found in all growth plates and 
all three zones, mostly in the lower proliferating and upper 
hypertrophic zones.[34] Our results were similar to previous 
findings. e PCNA-positive chondrocytes level was 
downregulated with age. In TC, the intensity was smoothly 
reduced with age. However, in the newly formed endosteal 
bone surface, the PCNA expression level was increased. Cell 
proliferation of TC was more active than SOS at the early 
stage, but at the later stage, the pattern was the opposite.
CONCLUSIONS
e purpose of this study was to investigate the postnatal 
developmental progression of the cranial base and tibia. 
Concerning the expression pattern of FGFR-1,  -2 in the 
cranial base and tibia development, this study had shown 
that FGFR-1 and FGFR-2 were predominantly expressed 
both in the cartilage phase and in the bone phase. ese 
findings imply that FGFR-1 and FGFR-2 may be involved 
in endochondral ossification and osteogenesis as well 
as chondrogenesis. Moreover, we can assume FGFR-
1 and FGFR-2 can control the cartilage through the cell 
proliferation of differentiation. FGFR-1 expressed in the 
hypertrophy zone is thought to be a negative regulator 
of chondrogenesis and control the differentiation of the 
hypertrophy cells in the cartilage. FGFR-2 expressed in the 
resting and proliferating zone is considered to be the positive 
regulators of chondrogenesis and control the proliferation 
and differentiation of chondrocytes in the process of 
chondrogenesis. In general, TC was sustained for a long 
time compared to SOS. With observing the localization of 
PCNA, we can suggest that the process of proliferation and 
differentiation in the TC is more active than SOS during early 
development.
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